XClose

Institute for Global Health

Home
Menu

UK-Korean partnership for a TB cohort

London & Seoul: tuberculosis patient cohorts to understand treatment response

Project Summary 

Each year, 9 million people are infected with a Mycobacterium tuberculosis infection globally. TB causes about 1.5 million deaths per year which is more than any other infectious disease.

The treatment of TB is complex and takes long. Even treatment of drug-sensitive disease generally lasts for six months. Efforts to shorten regimens have proved unpromising and treatment outcome of TB also remains difficult to predict. Even though such predictions could support research and development focused on treatment shortening and personalisation. 

This partnership award will undertake the groundwork for future TB patient cohorts in London and Seoul through capacity building. 

Links to other research

Other research from the UCL Centre for Pragmatic Global Health Trials

Other research from IGH on TB, Infectious Diseases and Personalised Medicine

Other research from IGH in the UK and Korea